Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07512271 · ClinicalTrials.gov registry record · NA
Generative AI Patient Education Module for Breast Oncology
A NA study, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT07512271 is a NA study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 35 participants.
The verdict
NCT07512271, a NA study, has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate sites.
Interventions
- OTHER Survey (Participant)
- OTHER OpenEvidence CareConnect
- OTHER Survey (Provider)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2026-08-15 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07512271
The ClinicalTrials.gov registry entry for NCT07512271 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Survey (Participant) is the first listed.
NCT07512271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07512271 about?
NCT07512271 is a clinical study titled "Generative AI Patient Education Module for Breast Oncology". This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate ...
What is the current status of trial NCT07512271?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2026-08-15. Estimated completion is 2027-01-31.
What interventions are being tested in trial NCT07512271?
The interventions under investigation include: Survey (Participant) (OTHER), OpenEvidence CareConnect (OTHER), Survey (Provider) (OTHER).
Who is sponsoring clinical trial NCT07512271?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.